RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Utah Medical Products Stock

Utah Medical Products EBIT 2025

Utah Medical Products EBIT

15.73 M USD

Ticker

UTMD

ISIN

US9174881089

WKN

882656

In 2025, Utah Medical Products's EBIT was 15.73 M USD, a -14.67% increase from the 18.44 M USD EBIT recorded in the previous year.

The Utah Medical Products EBIT history

YEAREBIT (undefined USD)
202415.73
202318.44
202220.46
202118.9
202013.71
201917.63
201818.7
201719.01
201616.19
201515.65
201416.2
201314.83
201215.2
201111.84
20108.92
20099.43
200810.39
200710.76
200610.84
20059.24

Utah Medical Products Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Utah Medical Products, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Utah Medical Products from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Utah Medical Products’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Utah Medical Products. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Utah Medical Products’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Utah Medical Products’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Utah Medical Products’s growth potential.

Utah Medical Products Revenue, EBIT and net profit per share

DateUtah Medical Products RevenueUtah Medical Products EBITUtah Medical Products Net Income
202440.9 M undefined15.73 M undefined13.87 M undefined
202350.22 M undefined18.44 M undefined16.64 M undefined
202252.28 M undefined20.46 M undefined16.47 M undefined
202149.05 M undefined18.9 M undefined14.79 M undefined
202042.18 M undefined13.71 M undefined10.8 M undefined
201946.9 M undefined17.63 M undefined14.73 M undefined
201842 M undefined18.7 M undefined18.56 M undefined
201741.41 M undefined19.01 M undefined8.51 M undefined
201639.3 M undefined16.19 M undefined12.13 M undefined
201540.16 M undefined15.65 M undefined11.84 M undefined
201441.28 M undefined16.2 M undefined11.38 M undefined
201340.49 M undefined14.83 M undefined11.41 M undefined
201241.55 M undefined15.2 M undefined10.17 M undefined
201137.86 M undefined11.84 M undefined7.41 M undefined
201025.12 M undefined8.92 M undefined6.01 M undefined
200925.92 M undefined9.43 M undefined6.26 M undefined
200827.78 M undefined10.39 M undefined7.21 M undefined
200728.5 M undefined10.76 M undefined7.91 M undefined
200628.75 M undefined10.84 M undefined8.17 M undefined
200527.69 M undefined9.24 M undefined7.55 M undefined

Utah Medical Products stock margins

The Utah Medical Products margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Utah Medical Products. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Utah Medical Products.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Utah Medical Products's sales revenue. A higher gross margin percentage indicates that the Utah Medical Products retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Utah Medical Products's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Utah Medical Products's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Utah Medical Products's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Utah Medical Products. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Utah Medical Products's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Utah Medical Products Margin History

Utah Medical Products Gross marginUtah Medical Products Profit marginUtah Medical Products EBIT marginUtah Medical Products Profit margin
202459.03 %38.46 %33.92 %
202359.81 %36.71 %33.12 %
202261.59 %39.14 %31.5 %
202163.04 %38.53 %30.15 %
202060.57 %32.5 %25.6 %
201962.84 %37.59 %31.41 %
201862.64 %44.52 %44.19 %
201763.75 %45.91 %20.55 %
201660.28 %41.2 %30.87 %
201560.23 %38.97 %29.48 %
201460.51 %39.24 %27.57 %
201359.94 %36.63 %28.18 %
201260.91 %36.58 %24.48 %
201159.17 %31.27 %19.57 %
201052.59 %35.51 %23.93 %
200953.2 %36.38 %24.15 %
200854.07 %37.4 %25.95 %
200755.4 %37.75 %27.75 %
200656.17 %37.7 %28.42 %
200556.88 %33.37 %27.27 %

Utah Medical Products Aktienanalyse

What does Utah Medical Products do?

Utah Medical Products Inc. (UMPI) is a US-based company specializing in medical devices and products. It was founded in 1978 and has since developed an impressive range of innovative products. UMPI began with the idea of creating a better device for monitoring pregnant women and their unborn children. The first product, called "FetalGard," was a non-invasive device for quickly and accurately measuring fetal heart rates. This technology was revolutionary at the time and helped doctors and nurses make accurate diagnoses and ensure optimal obstetric care. UMPI has expanded its product range and now covers a variety of medical specialties, including gynecology/restorative, neonatology/perinatology, and blood pressure measurement. In the gynecology/restorative field, UMPI offers a wide range of products to support women's medical needs, including devices for the diagnosis and treatment of cervical cancer, obstetric instruments, and products for post-gynecological surgery recovery. The neonatology/perinatology field includes products for preterm birth prevention and support of premature infants. UMPI, for example, has developed a variety of devices for monitoring and supporting newborns, such as the "Flexxus Hydrosense," which can contribute to measuring fluid levels in newborns. In the field of blood pressure measurement, UMPI has developed a range of devices to assist doctors and medical personnel in conducting blood pressure measurements. The company is known for its highly accurate blood pressure monitors, such as the "Deltran Plus," which can be used for blood pressure measurements in adults, children, and infants. UMPI's business model focuses on the development of high-quality medical devices. The company aims to create value through these devices and help doctors and medical personnel achieve better medical outcomes. The company is proud that its products help improve patients' lives and enhance the performance of healthcare professionals. UMPI has a network of distributors and partners worldwide who contribute to making high-quality products available in the market. The company places great importance on compliance with standards and regulations and works closely with the relevant regulatory authorities. Overall, Utah Medical Products Inc. has an excellent reputation in the medical industry and is considered a reliable provider of high-quality medical devices and products. Through its innovative technology and commitment to improving medical outcomes, the company has made a significant contribution to the medical industry and will continue to play an important role in the future. Utah Medical Products ist eines der beliebtesten Unternehmen auf Eulerpool.com.

EBIT Details

Analyzing Utah Medical Products's EBIT

Utah Medical Products's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of Utah Medical Products's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

Utah Medical Products's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in Utah Medical Products’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about Utah Medical Products stock

How much did Utah Medical Products achieve in EBIT for the current year?

In the current year, Utah Medical Products has achieved an EBIT of 15.73 M USD.

What is EBIT?

EBIT stands for Earnings Before Interest and Taxes and refers to the profit before interest and taxes of a company Utah Medical Products.

How has the EBIT of Utah Medical Products developed in recent years?

The EBIT of Utah Medical Products has increased by -14.666% decreased compared to the previous year.

What does EBIT mean for investors?

EBIT provides investors with insights into a company's profitability as it reflects the profit before interest expenses and taxes.

Why is EBIT an important indicator for investors?

Since EBIT provides a more direct insight into a company's profit than net income, it is an important indicator for investors to assess the profitability of a company.

Why do EBIT values fluctuate?

EBIT values can fluctuate as they are influenced by various factors, such as revenue, costs, and tax effects.

What role does tax burden play in EBIT?

Tax burdens have a direct impact on a company's EBIT, as they are deducted from the profit.

How is EBIT presented in the balance sheet of the company Utah Medical Products?

The EBIT of Utah Medical Products is listed in the income statement.

Can EBIT be used as a single indicator for evaluating a company?

EBIT is an important indicator for evaluating a company, but additional financial ratios should also be considered to get a comprehensive picture.

Why is EBIT not equal to net profit?

The net profit of a company includes taxes and interest, while EBIT represents the profit before interest and taxes.

How much dividend does Utah Medical Products pay?

Over the past 12 months, Utah Medical Products paid a dividend of 1.2 USD . This corresponds to a dividend yield of about 2.07 %. For the coming 12 months, Utah Medical Products is expected to pay a dividend of 1.2 USD.

What is the dividend yield of Utah Medical Products?

The current dividend yield of Utah Medical Products is 2.07 %.

When does Utah Medical Products pay dividends?

Utah Medical Products pays a quarterly dividend. This is distributed in the months of October, January, April, July.

How secure is the dividend of Utah Medical Products?

Utah Medical Products paid dividends every year for the past 20 years.

What is the dividend of Utah Medical Products?

For the upcoming 12 months, dividends amounting to 1.2 USD are expected. This corresponds to a dividend yield of 2.07 %.

In which sector is Utah Medical Products located?

Utah Medical Products is assigned to the 'Health' sector.

Wann musste ich die Aktien von Utah Medical Products kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Utah Medical Products from 7/3/2025 amounting to 0.305 USD, you needed to have the stock in your portfolio before the ex-date on 6/16/2025.

When did Utah Medical Products pay the last dividend?

The last dividend was paid out on 7/3/2025.

What was the dividend of Utah Medical Products in the year 2024?

In the year 2024, Utah Medical Products distributed 1.185 USD as dividends.

In which currency does Utah Medical Products pay out the dividend?

The dividends of Utah Medical Products are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Utah Medical Products

Our stock analysis for Utah Medical Products Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Utah Medical Products Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.